Debiopharm in den Nachrichten
Entwicklung von verschreibungspflichtigen Medikamenten
Tamtam hat 20 aktuelle Artikel über Debiopharm gefunden.
- Peptron launches next-generation ADC research collaboration with Debiopharm
- Peptone Signs Joint Research Agreement with Swiss Debiopharm for ADC Development
- Peptron Partners with Switzerland's Debiopharm to Develop Next-Generation ADC
- Peptron launches next-generation ADC research collaboration with Debiopharm
- Peptone Signs Joint Research Agreement with Swiss Debiopharm for ADC Development
- Peptron Partners with Switzerland's Debiopharm to Develop Next-Generation ADC
- Peptone Signs Joint Research Agreement with Swiss Debiopharm for ADC Development
- Genome & Company Eyes Big Pharma Licensing as Partners Expand Trials
- Acromegaly Market Shows Strong Future Potential with Increasing Industry Investments by 2036 – DelveInsight | Crinetics, Camurus, Chiesi, Debiopharm International SA, AstraZeneca, Marea Therapeutics
- Following Oral Presentation of Phase I Data at AACR 2026, Debiopharm Announces FDA Fast Track Designation for Lunresertib in Combination With Zedoresertib for Genomic-Defined Platinum-Resistant Ovarian Cancer
- Debiopharm’s lunresertib and zedoresertib combo picks up FDA Fast Track status for ovarian cancer
- Debiopharm to Unveil New Pre-Clinical and Clinical Research Advances in DDR Inhibition, Dual Payload ADCs, and AI-Driven Biomarkers at AACR 2026
- 2026 as an Implementation Year for AI in Drug Development
- Veeva Systems Inc. acquired Yonalink Ltd. from Debiopharm Innovation Fund SA and other shareholders.
- GARDP and Debiopharm Partner to Advance Antibiotic for Drug-Resistant Gonorrhea
- GARDP und Debiopharm gehen Partnerschaft zur Förderung der Entwicklung eines neuartigen Medikaments gegen Gonorrhoe ein.
- GARDP, Debiopharm Partner to Develop Novel Gonorrhea Drug
- GARDP, Debiopharm to collaborate on new gonorrhea antibiotic
- Debiopharm Deploys Genialis Software to Advance AI-Based Biomarker Discovery
- Debiopharm Deploys Genialis Software to Advance AI-Based Biomarker Discovery
Von Tamtam gesammelte Artikel, die sich auf das Unternehmen beziehen, die neuesten zuerst. Jeder verlinkt auf seine Quelle.
Sie verkaufen an Unternehmen wie Debiopharm?
Tamtam findet die Unternehmen, die zu Ihrem idealen Kunden passen, recherchiert jeden Account und sagt Ihnen, wen Sie wann kontaktieren sollten.
Ähnliche Unternehmen finden